Please assess the completion status of the following clinical trial:

Trial Title: Prognostic and Predictive Impact of uPA/PAI-1

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* N0 breast cancer patients tumor size \>/= 1 and \</= 5 cm in diameter undergoing standard loco-regional treatment~Exclusion Criteria:~* M1 status

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: NO_INTERVENTION): Low uPA/PAI-1: Observation
- B2 (Type: NO_INTERVENTION): High uPA/PAI-1: Observation
- B3 (Type: NO_INTERVENTION): High uPA/PAI-1: refused randomization
- B1 (Type: ACTIVE_COMPARATOR): High uPA/PAi-1: CMF chemotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).